Saturday 17 October 2026 Export UTMD’s income statement to Excel — free account

Utah Medical Products, Inc.

UTMD Healthcare Medical Instruments & Supplies

Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024. In the quarter to June 2026, revenue fell 14.3%, EPS fell 10.6% and free cash flow fell 55.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.

74.51 0.41 −0.55%

Follow UTMD

Alert me

Market cap: $237.8M
P/E: 22.7×
Fwd P/E: 28.7×
Dividend yield: 1.66%
F-score: 6/9
Altman Z: 36.25
Beneish M: −2.68
Dividend safety: 82/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	21.03	18.34	16.08	17.79	+8 more quarters Free account
P/S ratio Full definition →	6.08	5.26	4.71	5.23
P/FCF ratio Full definition →	19.19	15.16	12.66	14.55
P/Operating CF Full definition →	158.81	63.51	52.15	52.07
P/B ratio Full definition →	1.80	1.64	1.52	1.71
Price to Tangible BV Full definition →	2.04	1.86	1.74	1.96
EV/Sales Full definition →	3.69	2.96	2.51	3.07
EV/EBITDA Full definition →	10.46	8.05	6.70	7.98
EV/Operating CF Full definition →	11.23	8.32	6.57	8.38
EV/FCF Full definition →	11.63	8.53	6.74	8.55
Quick Ratio Full definition →	44.01	25.97	34.36	29.22
Current Ratio Full definition →	48.62	28.64	37.62	32.06
Net Debt/EBITDA Full definition →	(30.29)	(26.87)	(26.78)	(24.93)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.29	0.30	0.31	0.31
Operating CF/Net income Full definition →	0.51	1.19	1.36	1.47
Capex/Depreciation Full definition →	(0.56)	(0.19)	(0.14)	(0.04)
Research and Development Expense of Revenue Full definition →	1.81%	1.77%	2.34%	1.70%
Selling, General and Administrative Expense of Revenue Full definition →	22.92%	29.39%	28.86%	28.80%
Intangible Assets out of Total Assets Full definition →	0.11	0.11	0.12	0.13
Share Based Compensation of Revenue Full definition →	0.84%	1.38%	1.23%	0.96%
Graham Net Nets Full definition →	0.45	0.49	0.52	0.46
Graham Number Full definition →	53.18	53.61	53.69	54.19
Earnings Yield Full definition →	4.76%	5.45%	6.22%	5.62%
Free Cash Flow Yield Full definition →	5.21%	6.59%	7.90%	6.87%
Revenue per Share Full definition →	2.68	2.74	2.79	3.06
Operating CF per Share Full definition →	0.43	0.98	1.07	1.21
Capex per Share Full definition →	(0.04)	(0.04)	(0.03)	(0.01)
Free Cash Flow per Share Full definition →	0.39	0.94	1.04	1.20
Cash per Share Full definition →	27.49	27.44	26.47	26.28
Shareholders Equity per Share Full definition →	38.33	37.79	36.81	36.87
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	38.33	37.79	36.81	36.87
Free Cash Flow Full definition →	1.25	2.98	3.37	3.85
Working Capital Full definition →	98.57	96.87	95.14	93.52
Capital Expenditures Full definition →	(0.13)	(0.13)	(0.11)	(0.03)
Net Current Asset Value Full definition →	98.10	96.37	94.47	92.81
EV/EBIT Full definition →	12.96	10.26	8.47	9.98
Capex to Sales Full definition →	0.02	0.01	0.01	0.00
Price to Operating Income Full definition →	21.39	18.26	15.90	16.98
Other line items
Average Receivables Full definition →	3.60	3.79	3.81	3.72
Average Payables Full definition →	0.81	1.05	0.80	0.88
Average Inventory Full definition →	8.62	8.69	8.37	8.61
Average Assets Full definition →	122.69	123.45	122.54	125.83
Average Common Equity Full definition →	119.78	118.71	118.35	121.22

Fold the line items

Columns are period end dates

Stockrow Weekly